Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
posted on
Jun 22, 2020 08:50AM
"Filing of a New Drug Application (NDA) with the FDA is possible following unequivocal efficacy at an interim analysis of BETonMACE2"
Timeline for the trial could be cut short due to the first bullet point....halted early for overwhelming efficacy...I think chances are better than 50/50 we see that down the road.